Yan Wu
Yan Wu
Verified email at bidmc.harvard.edu
Cited by
Cited by
Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α
ID Mascanfroni, MC Takenaka, A Yeste, B Patel, Y Wu, JE Kenison, ...
Nature medicine 21 (6), 638-646, 2015
IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39
ID Mascanfroni, A Yeste, SM Vieira, EJ Burns, B Patel, I Sloma, Y Wu, ...
Nature immunology 14 (10), 1054, 2013
CD39/ENTPD1 expression by CD4+ Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice
X Sun, Y Wu, W Gao, K Enjyoji, E Csizmadia, CE Müller, T Murakami, ...
Gastroenterology 139 (3), 1030-1040, 2010
Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation
SC Robson, Y Wu, X Sun, C Knosalla, K Dwyer, K Enjyoji
Seminars in thrombosis and hemostasis 31 (02), 217-233, 2005
An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling
Y Wang, KM Telesford, J Ochoa-Repáraz, S Haque-Begum, M Christy, ...
Nature communications 5 (1), 1-10, 2014
Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis
R Miao, H Luo, H Zhou, G Li, D Bu, X Yang, X Zhao, H Zhang, S Liu, ...
Journal of hepatology 61 (4), 840-849, 2014
Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate
L Feng, X Sun, E Csizmadia, L Han, S Bian, T Murakami, X Wang, ...
Neoplasia 13 (3), 206-IN2, 2011
Activated CD69+ T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages
Q Zhao, DM Kuang, Y Wu, X Xiao, XF Li, TJ Li, L Zheng
The Journal of Immunology 188 (3), 1117-1124, 2012
Deletion of cd39/entpd1 results in hepatic insulin resistance
K Enjyoji, K Kotani, C Thukral, B Blumel, X Sun, Y Wu, M Imai, D Friedman, ...
Diabetes 57 (9), 2311-2320, 2008
Sublethal heat treatment promotes epithelial‐mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma
S Yoshida, M Kornek, N Ikenaga, M Schmelzle, R Masuzaki, E Csizmadia, ...
Hepatology 58 (5), 1667-1680, 2013
Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice
HS Moon, X Liu, JM Nagel, JP Chamberland, KN Diakopoulos, ...
Gut 62 (4), 561-570, 2013
Natural killer T cell dysfunction in CD39‐null mice protects against concanavalin A–induced hepatitis
G Beldi, Y Wu, Y Banz, M Nowak, L Miller, K Enjyoji, A Haschemi, ...
Hepatology 48 (3), 841-852, 2008
Isolated CD39 Expression on CD4+ T Cells Denotes both Regulatory and Memory Populations
Q Zhou, J Yan, P Putheti, Y Wu, X Sun, V Toxavidis, J Tigges, N Kassam, ...
American Journal of Transplantation 9 (10), 2303-2311, 2009
Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice
SW Jackson, T Hoshi, Y Wu, X Sun, K Enjyoji, E Cszimadia, C Sundberg, ...
The American journal of pathology 171 (4), 1395-1404, 2007
P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death
S Bian, X Sun, A Bai, C Zhang, L Li, K Enjyoji, WG Junger, SC Robson, ...
PloS one 8 (4), e60184, 2013
The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism
G Beldi, K Enjyoji, Y Wu, L Miller, Y Banz, X Sun, SC Robson
Frontiers in bioscience: a journal and virtual library 13, 2588, 2008
Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration
G Beldi, Y Wu, X Sun, M Imai, K Enjyoji, E Csizmadia, D Candinas, L Erb, ...
Gastroenterology 135 (5), 1751-1760, 2008
CD39 and CD161 modulate Th17 responses in Crohn's disease
A Bai, A Moss, E Kokkotou, A Usheva, X Sun, A Cheifetz, Y Zheng, ...
The Journal of Immunology 193 (7), 3366-3377, 2014
Increased autophagy sustains the survival and pro-tumourigenic effects of neutrophils in human hepatocellular carcinoma
XF Li, DP Chen, FZ Ouyang, MM Chen, Y Wu, DM Kuang, L Zheng
Journal of hepatology 62 (1), 131-139, 2015
Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice
G Beldi, Y Banz, A Kroemer, X Sun, Y Wu, N Graubardt, A Rellstab, ...
Hepatology 51 (5), 1702-1711, 2010
The system can't perform the operation now. Try again later.
Articles 1–20